{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:13:40Z","timestamp":1787062420361,"version":"build-2736575974"},"reference-count":39,"publisher":"The Endocrine Society","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,6,1]]},"DOI":"10.1210\/jc.2018-00259","type":"journal-article","created":{"date-parts":[[2018,3,30]],"date-time":"2018-03-30T14:03:28Z","timestamp":1522418608000},"page":"2354-2361","source":"Crossref","is-referenced-by-count":38,"title":["High Fear of Disease Occurrence Is Associated With Low Quality of Life in Patients With Multiple Endocrine Neoplasia Type 1: Results From the Dutch MEN1 Study Group"],"prefix":"10.1210","volume":"103","author":[{"given":"Rachel S","family":"van Leeuwaarde","sequence":"first","affiliation":[{"name":"Department of Endocrine Oncology, University Medical Center Utrecht, Utrecht, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina R C","family":"Pieterman","sequence":"additional","affiliation":[{"name":"Dutch MEN Advocacy Group, Department of Endocrine Oncology, University Medical Center Utrecht, Utrecht, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eveline M A","family":"Bleiker","sequence":"additional","affiliation":[{"name":"Department of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute\u2014Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olaf M","family":"Dekkers","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Leiden University Medical Center, Leiden, Netherlands"},{"name":"Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anouk N","family":"van der Horst-Schrivers","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ad R","family":"Hermus","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Radboud University Medical Center, Nijmegen, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wouter W","family":"de Herder","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Erasmus Medical Center, Rotterdam, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeleine L","family":"Drent","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Section of Endocrinology, VU University Medical Center, Amsterdam, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter H","family":"Bisschop","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Academic Medical Center, Amsterdam, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bas","family":"Havekes","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Endocrinology, Maastricht University Medical Center, Maastricht, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menno R","family":"Vriens","sequence":"additional","affiliation":[{"name":"Department of Endocrine Surgery, University Medical Center Utrecht, Utrecht, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerlof D","family":"Valk","sequence":"additional","affiliation":[{"name":"Department of Endocrine Oncology, University Medical Center Utrecht, Utrecht, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2018,3,30]]},"reference":[{"issue":"5311","key":"key\n\t\t\t\t20180606135807_B1","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1126\/science.276.5311.404","article-title":"Positional cloning of the gene for multiple endocrine neoplasia-type 1","volume":"276","author":"Chandrasekharappa","year":"1997","journal-title":"Science"},{"issue":"6","key":"key\n\t\t\t\t20180606135807_B2","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1001\/archsurg.137.6.641","article-title":"Genotype-phenotype analysis in multiple endocrine neoplasia type 1","volume":"137","author":"Kouvaraki","year":"2002","journal-title":"Arch Surg"},{"key":"key\n\t\t\t\t20180606135807_B3","first-page":"19","article-title":"Clinical studies of multiple neoplasia type 1","volume":"90","author":"Trump","year":"1997","journal-title":"Q J Med"},{"issue":"1","key":"key\n\t\t\t\t20180606135807_B4","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/s12916-016-0708-1","article-title":"MEN1 redefined, a clinical comparison of mutation-positive and mutation-negative patients","volume":"14","author":"de Laat","year":"2016","journal-title":"BMC Med"},{"key":"key\n\t\t\t\t20180606135807_B5","first-page":"182","article-title":"MEN1 redefined: a clinical comparison of mutation-positive and mutation-negative patients. Results from the DutchMEN1 study group","volume-title":"BMC Medicine","author":"de Laat","year":"2016"},{"issue":"6","key":"key\n\t\t\t\t20180606135807_B6","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1056\/NEJMc1406028","article-title":"Breast-cancer predisposition in multiple endocrine neoplasia type 1","volume":"371","author":"Dreijerink","year":"2014","journal-title":"N Engl J Med"},{"issue":"3","key":"key\n\t\t\t\t20180606135807_B7","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/MD.0b013e3182954af1","article-title":"Causes of death and prognostic factors in multiple endocrine neoplasia type 1: a prospective study: comparison of 106 MEN1\/Zollinger-Ellison syndrome patients with 1613 literature MEN1 patients with or without pancreatic endocrine tumors","volume":"92","author":"Ito","year":"2013","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"key\n\t\t\t\t20180606135807_B8","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s00268-009-0290-1","article-title":"Risk factors and causes of death in MEN1 disease. A GTE (Groupe d\u2019Etude des Tumeurs Endocrines) cohort study among 758 patients","volume":"34","author":"Goudet","year":"2010","journal-title":"World J Surg"},{"issue":"6","key":"key\n\t\t\t\t20180606135807_B9","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s002689900438","article-title":"Lethality of multiple endocrine neoplasia type I","volume":"22","author":"Doherty","year":"1998","journal-title":"World J Surg"},{"issue":"4","key":"key\n\t\t\t\t20180606135807_B10","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/j.1365-2265.2008.03324.x","article-title":"Multiple endocrine neoplasia type 1 (MEN1): its manifestations and effect of genetic screening on clinical outcome","volume":"70","author":"Pieterman","year":"2009","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"18","key":"key\n\t\t\t\t20180606135807_B11","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1200\/JCO.2009.27.2112","article-title":"Genetic testing in Li-Fraumeni syndrome: uptake and psychosocial consequences","volume":"28","author":"Lammens","year":"2010","journal-title":"J Clin Oncol"},{"issue":"5","key":"key\n\t\t\t\t20180606135807_B12","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1399-0004.2010.01333.x","article-title":"Psychosocial impact of Von Hippel-Lindau disease: levels and sources of distress","volume":"77","author":"Lammens","year":"2010","journal-title":"Clin Genet"},{"issue":"3","key":"key\n\t\t\t\t20180606135807_B13","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/pon.1570","article-title":"Psychological distress and use of psychosocial support in familial adenomatous polyposis","volume":"19","author":"Douma","year":"2010","journal-title":"Psychooncology"},{"key":"key\n\t\t\t\t20180606135807_B14","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1023\/A:1023252107120","article-title":"Quality of life in patients with multiple endocrine neoplasia type 1 (MEN1)","volume":"1","author":"Berglund","year":"2003","journal-title":"Fam Cancer"},{"issue":"6","key":"key\n\t\t\t\t20180606135807_B15","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/j.surg.2017.07.023","article-title":"Disease and treatment factors associated with lower quality of life scores in adults with multiple endocrine neoplasia type I","volume":"162","author":"Goswami","year":"2017","journal-title":"Surgery"},{"issue":"4","key":"key\n\t\t\t\t20180606135807_B16","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1200\/JCO.1994.12.4.843","article-title":"Attitudes about genetic testing for breast-ovarian cancer susceptibility","volume":"12","author":"Lerman","year":"1994","journal-title":"J Clin Oncol"},{"issue":"1","key":"key\n\t\t\t\t20180606135807_B17","doi-asserted-by":"crossref","first-page":"E44","DOI":"10.1097\/NCC.0b013e3182813a17","article-title":"The Cancer Worry Scale: detecting fear of recurrence in breast cancer survivors","volume":"37","author":"Custers","year":"2014","journal-title":"Cancer Nurs"},{"issue":"3","key":"key\n\t\t\t\t20180606135807_B18","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s00520-012-1685-3","article-title":"Does fear of cancer recurrence predict cancer survivors\u2019 health care use","volume":"21","author":"Lebel","year":"2013","journal-title":"Support Care Cancer"},{"issue":"1","key":"key\n\t\t\t\t20180606135807_B19","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s11764-016-0558-z","article-title":"Towards an evidence-based model of fear of cancer recurrence for breast cancer survivors","volume":"11","author":"Custers","year":"2017","journal-title":"J Cancer Surviv"},{"issue":"5","key":"key\n\t\t\t\t20180606135807_B20","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1002\/pon.3114","article-title":"Factors reported to influence fear of recurrence in cancer patients: a systematic review","volume":"22","author":"Crist","year":"2013","journal-title":"Psychooncology"},{"issue":"3","key":"key\n\t\t\t\t20180606135807_B21","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1007\/s11764-013-0272-z","article-title":"Fear of cancer recurrence in adult cancer survivors: a systematic review of quantitative studies","volume":"7","author":"Simard","year":"2013","journal-title":"J Cancer Surviv"},{"issue":"6","key":"key\n\t\t\t\t20180606135807_B22","first-page":"95","article-title":"Fear of cancer recurrence: a literature review and proposed cognitive formulation to explain exacerbation of recurrent fears","volume":"1997","author":"Lee-Jones","year":"1996","journal-title":"Psychooncology"},{"issue":"11","key":"key\n\t\t\t\t20180606135807_B23","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1007\/s00520-011-1371-x","article-title":"Fear of cancer recurrence in young women with a history of early-stage breast cancer: a cross-sectional study of prevalence and association with health behaviours","volume":"20","author":"Thewes","year":"2012","journal-title":"Support Care Cancer"},{"key":"key\n\t\t\t\t20180606135807_B24","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/pon.2070","article-title":"Fear of cancer recurrence: a systematic literature review of self-report measures","volume":"21","author":"Thewes","year":"2012","journal-title":"Psychooncology"},{"issue":"7","key":"key\n\t\t\t\t20180606135807_B25","doi-asserted-by":"crossref","first-page":"821","DOI":"10.3109\/0284186X.2016.1150607","article-title":"Fear of cancer recurrence in prostate cancer survivors","volume":"55","author":"van de Wal","year":"2016","journal-title":"Acta Oncol"},{"key":"key\n\t\t\t\t20180606135807_B26","doi-asserted-by":"crossref","unstructured":"Thewes B , KaalSEJ, CustersJAE, Manten-HorstE, JansenR, ServaesP, van der GraafWTA, PrinsJB, HussonO. Prevalence and correlates of high fear of cancer recurrence in late adolescents and young adults consulting a specialist adolescent and young adult (AYA) cancer service [published online ahead of print November 22, 2017]. Support Care Cancer. doi:10.1007\/s00520-017-3975-2.","DOI":"10.1007\/s00520-017-3975-2"},{"issue":"29","key":"key\n\t\t\t\t20180606135807_B27","doi-asserted-by":"crossref","first-page":"3275","DOI":"10.1200\/JCO.2017.72.8212","article-title":"Fear of cancer recurrence in an era of personalized medicine","volume":"35","author":"Thewes","year":"2017","journal-title":"J Clin Oncol"},{"issue":"8","key":"key\n\t\t\t\t20180606135807_B28","doi-asserted-by":"crossref","first-page":"3265","DOI":"10.1007\/s00520-016-3272-5","article-title":"From normal response to clinical problem: definition and clinical features of fear of cancer recurrence","volume":"24","author":"Lebel","year":"2016","journal-title":"Support Care Cancer"},{"issue":"2","key":"key\n\t\t\t\t20180606135807_B29","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/01.sla.0000197715.96762.68","article-title":"Epidemiology data on 108 MEN 1 patients from the GTE with isolated nonfunctioning tumors of the pancreas","volume":"243","author":"Triponez","year":"2006","journal-title":"Ann Surg"},{"key":"key\n\t\t\t\t20180606135807_B30","doi-asserted-by":"crossref","unstructured":"Geerdink EAM , LuijtRBVan Der, LipsCJM. Do patients with multiple endocrine neoplasia syndrome type 1 benefit from periodical screening? 2003;149(6):577\u2013582.","DOI":"10.1530\/eje.0.1490577"},{"issue":"11","key":"key\n\t\t\t\t20180606135807_B31","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1007\/s002680010237","article-title":"Are patients with multiple endocrine neoplasia type I prone to premature death","volume":"24","author":"Dean","year":"2000","journal-title":"World J Surg"},{"issue":"2","key":"key\n\t\t\t\t20180606135807_B32","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s12020-017-1234-4","article-title":"Multiple endocrine neoplasia syndrome type 1: institution, management, and data analysis of a nationwide multicenter patient database","volume":"58","author":"Giusti","year":"2017","journal-title":"Endocrine"},{"issue":"9","key":"key\n\t\t\t\t20180606135807_B33","doi-asserted-by":"crossref","first-page":"3288","DOI":"10.1210\/JC.2015-2015","article-title":"Long-term natural course of pituitary tumors in patients with MEN1: results from the Dutch MEN1 study group (DMSG)","volume":"100","author":"de Laat","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"key\n\t\t\t\t20180606135807_B34","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1136\/oemed-2013-101891","article-title":"Health effects of employment: a systematic review of prospective studies","volume":"71","author":"van der Noordt","year":"2014","journal-title":"Occup Environ Med"},{"issue":"2","key":"key\n\t\t\t\t20180606135807_B35","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1080\/0284186X.2016.1266083","article-title":"Sustained employability and health-related quality of life in cancer survivors up to four years after diagnosis","volume":"56","author":"Duijts","year":"2017","journal-title":"Acta Oncol"},{"issue":"8","key":"key\n\t\t\t\t20180606135807_B36","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.3109\/0284186X.2014.1003960","article-title":"Fear of progression in patients with gastrointestinal stromal tumors (GIST): is extended lifetime related to the Sword of Damocles","volume":"54","author":"Custers","year":"2015","journal-title":"Acta Oncol"},{"issue":"1","key":"key\n\t\t\t\t20180606135807_B37","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1023\/A:1021447201809","article-title":"The unmet information and support needs of women with a family history of breast cancer: a descriptive survey","volume":"12","author":"Thewes","year":"2003","journal-title":"J Genet Couns"},{"issue":"2","key":"key\n\t\t\t\t20180606135807_B38","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s00520-015-2808-4","article-title":"Fear of cancer recurrence in colorectal cancer survivors","volume":"24","author":"Custers","year":"2016","journal-title":"Support Care Cancer"},{"issue":"36","key":"key\n\t\t\t\t20180606135807_B39","doi-asserted-by":"crossref","first-page":"4066","DOI":"10.1200\/JCO.2017.73.1257","article-title":"Randomized trial of ConquerFear: a novel, theoretically based psychosocial intervention for fear of cancer recurrence","volume":"35","author":"Butow","year":"2017","journal-title":"J. Clin. Oncol"}],"container-title":["The Journal of Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/103\/6\/2354\/25011341\/jc.2018-00259.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,13]],"date-time":"2019-10-13T15:44:20Z","timestamp":1570981460000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/103\/6\/2354\/4956607"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,30]]},"references-count":39,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2018,3,30]]},"published-print":{"date-parts":[[2018,6,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2018-00259","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,6]]},"published":{"date-parts":[[2018,3,30]]}}}